Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radha Rajasingham

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Open Forum Infectious Diseases|May 13, 2022
Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient TrialsSarah M Lofgren, Elizabeth C Okafor, Alanna A Colette, et al.
Medical Mycology|January 8, 2025
The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 2022Stewart Walukaga, Ann Fieberg, Abdu Musubire, et al.
BMC Neurology|June 14, 2017
Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohortsMartha P Montgomery, Noeline Nakasujja, Bozena M Morawski, et al.
The New England Journal of Medicine|June 26, 2014
Timing of antiretroviral therapy after diagnosis of cryptococcal meningitisDavid R Boulware, David B Meya, Conrad Muzoora, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2022
Outpatient Cryptococcal Antigen Screening Is Associated With Favorable Baseline Characteristics and Improved Survival in Persons With Cryptococcal Meningitis in UgandaAnna E Levin, Ananta S Bangdiwala, Elizabeth Nalintya, et al.
The American Journal of Tropical Medicine and Hygiene|April 15, 2025
Etiology and Outcomes of Meningitis among Adults in Three Ugandan Referral Hospitals, 2018-2023: A Prospective Cohort Study in a High-HIV Endemic SettingTimothy Mugabi, Suzan Namombwe, Biyue Dai, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|May 9, 2020
Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trialSylvain A Lother, Mahsa Abassi, Alyssa Agostinis, et al.
The Lancet. Global Health|January 31, 2025
Causes of HIV-related CNS infection in Cameroon, Malawi, and Tanzania: epidemiological findings from the DREAMM HIV-related CNS implementation studyCecilia Kanyama, Charles Kouanfack, Saulos Nyirenda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2020
Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical TrialsMatthew F Pullen, Katherine Huppler Hullsiek, Joshua Rhein, et al.
Annals of Internal Medicine|July 17, 2020
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized TrialCaleb P Skipper, Katelyn A Pastick, Nicole W Engen, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Open Forum Infectious Diseases|May 13, 2022
Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient TrialsSarah M Lofgren, Elizabeth C Okafor, Alanna A Colette, et al.
Medical Mycology|January 8, 2025
The evolution of HIV-associated cryptococcal meningitis in Uganda from 2010 to 2022Stewart Walukaga, Ann Fieberg, Abdu Musubire, et al.
BMC Neurology|June 14, 2017
Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohortsMartha P Montgomery, Noeline Nakasujja, Bozena M Morawski, et al.
The New England Journal of Medicine|June 26, 2014
Timing of antiretroviral therapy after diagnosis of cryptococcal meningitisDavid R Boulware, David B Meya, Conrad Muzoora, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2022
Outpatient Cryptococcal Antigen Screening Is Associated With Favorable Baseline Characteristics and Improved Survival in Persons With Cryptococcal Meningitis in UgandaAnna E Levin, Ananta S Bangdiwala, Elizabeth Nalintya, et al.
The American Journal of Tropical Medicine and Hygiene|April 15, 2025
Etiology and Outcomes of Meningitis among Adults in Three Ugandan Referral Hospitals, 2018-2023: A Prospective Cohort Study in a High-HIV Endemic SettingTimothy Mugabi, Suzan Namombwe, Biyue Dai, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|May 9, 2020
Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trialSylvain A Lother, Mahsa Abassi, Alyssa Agostinis, et al.
The Lancet. Global Health|January 31, 2025
Causes of HIV-related CNS infection in Cameroon, Malawi, and Tanzania: epidemiological findings from the DREAMM HIV-related CNS implementation studyCecilia Kanyama, Charles Kouanfack, Saulos Nyirenda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2020
Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical TrialsMatthew F Pullen, Katherine Huppler Hullsiek, Joshua Rhein, et al.
Annals of Internal Medicine|July 17, 2020
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized TrialCaleb P Skipper, Katelyn A Pastick, Nicole W Engen, et al.
Pageof 11